Long-Term Efficacy of Vismodegib After its Withdrawal and Patients’ Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI)

INTRODUCTION: Although non-melanoma skin cancers (NMSCs) are associated with a very low mortality risk, they have been reported to have a major impact on patients’ health-related quality of life (HRQoL). Vismodegib is a therapy for patients who are affected by locally advanced basal cell carcinoma (...

Descripción completa

Detalles Bibliográficos
Autores principales: Villani, Alessia, Megna, Matteo, Fabbrocini, Gabriella, Cappello, Milena, Luciano, Maria Antonietta, Costa, Claudia, Scalvenzi, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828856/
https://www.ncbi.nlm.nih.gov/pubmed/31506916
http://dx.doi.org/10.1007/s13555-019-00323-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828856/
https://www.ncbi.nlm.nih.gov/pubmed/31506916
http://dx.doi.org/10.1007/s13555-019-00323-4

Ejemplares similares